Design
Review
Authors
Loading...
Modest clinical results warrant caution against adoption; leaves open optimized preclinical strategies for cardiac regeneration.
While endogenous myocardial repair mechanisms and cardiac stem cells exist, their current clinical impact is modest, necessitating further preclinical research to unlock their therapeutic potential.
Schoenfeld et al. (2013) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: